Hey there, welcome to Neuropod, a channel covering everything related to Elon Musk's brain computer interface company, Neurolink. My name is Ryan Tanaka, and in this update episode, the first thing we'll cover is that Neuralink has officially announced they've completed their first human trial surgery in the United Kingdom. I'll discuss what was shared, and then we have this video of Nick Ray, Neuralink's eighth patient, controlling an assisted robotic arm.Then Neuralink has leased a 144,000q foot property ...

Medical Technology Advancement - Neuralink's BCI device enables ALS patient to control a robotic arm [1] - The BCI technology allows the patient to regain the ability to feed himself [1] - The patient expresses satisfaction and optimism about future advancements of the BCI [1] Company Impact - Neuralink team receives recognition for their work [1]

Company Development - Neuralink allowed a paralyzed ALS patient to control a robotic arm using his thoughts [1] - The patient was able to feed himself using the robotic arm [1]

Summary of Key Points from the Research Report Industry Overview - The report focuses on the **humanoid robot industry** and its developments showcased at the **China Industrial Industry Fair (CIIF)** held in Shanghai on **24 September 2025** [3][4]. Core Insights - **Hardware vs. Software**: Hardware is not seen as a bottleneck for humanoid robots, with significant cost reductions in components. The price for dexterous hands has decreased from **RMB50-100k** to **RMB10-60k** per hand, with Linkerbot's offering at **RMB8.8k** per hand [3]. However, software remains underdeveloped, with key AI models still in training [3]. - **Cost Reduction**: Overseas companies like Nidec are relocating supply chains to China, which is expected to further reduce costs in components as mass production of humanoid robots begins [3]. - **Software Development**: Unitree's recent open-sourcing of its world model aims to enhance the software ecosystem for humanoid robots, particularly benefiting educational institutions [3]. Company Highlights - **Inovance**: Unveiled new humanoid robot products, including a robotic arm and various actuators. The company plans to start commercial production in **2026**, with an estimated actuator value of **RMB34k/unit** by **2030**. The global humanoid robot market is projected to reach **1.1 million shipments** by **2030**, indicating a market size of approximately **RMB37 billion** [4]. - **Preferred Picks**: Inovance, Hongfa, and Shuanghuan are highlighted as preferred investment choices due to their strong market positions and growth potential [5][9]. Stock Ratings and Valuations - **Inovance (300124 CH)**: Current price **RMB86.33**, target price **RMB96.00**, with an upside of **11.2%**. The company is expected to benefit from a recovery in factory automation [6][10]. - **Hongfa (600885 CH)**: Current price **RMB25.74**, target price **RMB39.10**, with an upside of **51.9%**. Strong earnings momentum is anticipated due to new car model launches [6][10]. - **Shuanghuan (002472 CH)**: Current price **RMB51.31**, target price **RMB58.00**, with an upside of **13.0%**. Growth in smart drive units and robotic reducers is expected to drive future performance [6][10]. Risks and Considerations - **Inovance Risks**: Weaker-than-expected demand in automation and intense competition could impact margins [10]. - **Hongfa Risks**: Potential risks include slower-than-expected relay demand and cost declines [10]. - **Shuanghuan Risks**: Risks include slower commercialization of humanoid robots and lower-than-expected market share gains [10]. Additional Insights - The report emphasizes the importance of software development in the humanoid robot sector, indicating that while hardware costs are decreasing, the maturity of software solutions is critical for future growth [3][9]. - The anticipated growth in the humanoid robot market presents significant investment opportunities, particularly for companies that can innovate in both hardware and software [4][5].

Technological Advancement - Neuralink trial participant can control a robotic arm with their mind [1] - The technology enables writing and drawing via robotic arm control [1]